| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
American Journal of Clinical Nutrition, Vol 48, 343-349, Copyright © 1988 by The American Society for Clinical Nutrition, Inc
ORIGINAL RESEARCH COMMUNICATIONS |
CA Swanson, R Mansourian, H Dirren and CH Rapin
Human Nutrition Laboratory, Nestle Research Center, Vevey, Switzerland.
The zinc status of 53 healthy elderly subjects was evaluated. The dietary Zn intake estimated by 24-h recall was 9.2 mg/d and 65% of subjects had intakes less than two-thirds of the RDA. Mean serum Zn concentration (13.0 mumol/L) and urinary Zn excretion (7.0 mumol/d) were normal. The Zn content of platelets, mononuclear cells, and polymorphonuclear cells was 5.8, 147, and 135 nmol/10(9) cells, respectively. Seventeen subjects were supplemented for 28 d with 30 mg Zn/d. The mean concentration of Zn in serum and urine increased 24% and 2.5-fold, respectively. Zn content of platelets and leukocytes did not change with Zn supplementation. The concentration of visceral proteins (ie, albumin, prealbumin, transferrin, and retinol-binding protein) and immunoglobulins (ie, IgG, IgA, and IgM) did not change with Zn supplementation. The data indicate that aging per se does not necessarily imply poor Zn status.
This article has been cited by other articles:
|
|
 |
|
  S. Hughes and S. Samman The effect of zinc supplementation in humans on plasma lipids, antioxidant status and thrombogenesis. J. Am. Coll. Nutr., August 1, 2006; 25(4): 285 - 291. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. K. Baum, G. Shor-Posner, and A. Campa Zinc Status in Human Immunodeficiency Virus Infection J. Nutr., May 1, 2000; 130(5): 1421S - 1423. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. G. Baumgartner Invited Review: Trace Elements in Clinical Nutrition Nutr Clin Pract, December 1, 1993; 8(6): 251 - 263. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
